Real-Time Radioisotope Detection via Gamma Spectrum Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current technologies face challenges in accurately and timely detecting and quantifying radioisotopes, particularly in the context of rubidium-82 and strontium-82 generators, due to overlapping gamma ray spectra, which can lead to difficulties in distinguishing between rubidium-82 and strontium-85 emissions, potentially resulting in unsafe or inefficacious use of radiopharmaceuticals in nuclear medicine.

Innovation Solution

The implementation of a gamma ray detection system that uses a detector positioned adjacent to a flowing stream of eluate from a radioisotope generator, capable of resolving overlapping spectra by determining the activity of rubidium-82 and strontium-82 through distinct energy ranges, and employing an accumulator structure to separate and measure the activities of parent and daughter radioisotopes separately, allowing for real-time monitoring and adjustment of radioisotope levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If a gamma ray detector is used to detect emissions from a flowing stream of eluate, then real-time detection of radioisotope activity is achieved, but overlapping gamma ray spectra from rubidium-82 and strontium-85 make it difficult to accurately distinguish and quantify individual isotopes

Engineering Contradiction:
Improvedetection timeVSAvoidisotope identification accuracy
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The detection system segments the overlapping gamma ray spectrum into distinct energy ranges, with a first energy range (e.g., 511 keV) primarily associated with rubidium-82 and a second energy range (e.g., 514 keV) primarily associated with strontium-85. By analyzing gamma ray emissions in these segmented energy ranges separately, the system can distinguish and quantify individual isotopes even when their spectra overlap, resolving the measurement precision issue while maintaining real-time detection capability.

Inventive Principle:
Principle #1Segmentation

2Reliability

If the eluate is monitored in real-time to detect elevated strontium-82 levels, then patient safety is improved by preventing unsafe infusion, but the system complexity increases due to the need for sophisticated spectrum resolution and real-time analysis

Engineering Contradiction:
Improvepatient safetyVSAvoiddetection system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system continuously monitors gamma ray emissions from the flowing eluate in real-time, comparing the measured spectrum against reference spectra for rubidium-82 and strontium-85. When elevated strontium-82 levels are detected, the system provides immediate feedback by generating an alert or controlling a diverter valve to prevent infusion into the patient. This feedback mechanism ensures patient safety while automating the complex analysis process, reducing the burden on operators despite the sophisticated detection requirements.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If gamma ray emissions are measured in the 511 keV to 514 keV energy range to detect both rubidium-82 and strontium-85, then detection sensitivity is improved, but the ability to clearly attribute emissions to specific isotopes is reduced due to spectral overlap

Engineering Contradiction:
Improveisotope activity quantificationVSAvoidisotope emission attribution
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The system resolves the spectral overlap by adding an energy dimension to the analysis. Instead of attempting to attribute all gamma ray emissions in the 511-514 keV range to a single isotope, the system measures emissions across multiple energy channels and attributes them based on their energy values. By measuring gamma ray emissions in a first energy range (e.g., 511 keV) and a second energy range (e.g., 514 keV) separately and analyzing the distribution across this energy dimension, the system can clearly attribute emissions to specific isotopes while maintaining detection sensitivity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables accurate and timely detection and quantification of radioisotopes in real-time, preventing unsafe infusion of elevated strontium-82 levels into patients and optimizing the operation of radioisotope generators by distinguishing between overlapping gamma ray emissions and separating parent and daughter isotopes effectively.

Implementation Method 1

a gamma ray detector is positioned adjacent to a flowing stream of the eluate and used to detect gamma ray emissions emanating from the flowing stream

Methodology Applied
Scientific EffectGamma ray detection: Radiation

Implementation Method 2

Rubidium-82 is a radioactive decay product of strontium-82. Typically, strontium-rubidium generators contain strontium bound to a generator column through which an eluant is flushed during operation. As strontium-82 decays to rubidium-82, the rubidium-82 may release from the generator column and enter the eluate.

Methodology Applied
Scientific EffectRadioactive decay: Radioactive Decay

Data Source

PatentUS10012740B2Real time nuclear isotope detection
Publication Date: 2018.07.03 BRACCO DIAGNOSTICS INC
  • US10012740B2 patent drawing
  • US10012740B2 patent drawing
  • US10012740B2 patent drawing

AI summary

A radioisotope generator that releases a daughter radioisotope from radioactive decay of a corresponding parent isotope, such as a 82Sr/82Rb radioisotope generator or 68Ge/68Ga radioisotope generator, may be used to generate radioisotopes for medical imaging applications. In some examples, a gamma ray detector is positioned to detect gamma rays emanating from radioactive eluate flowing from the generator. Based on the detected gamma rays, an activity of the daughter radioisotope in the eluate and an activity of the parent radioisotope in the eluate may be determined. Depending on the application, the activity of the daughter radioisotope and the activity of the parent radioisotope may be determined in substantially real time, e.g., so that the eluate can be diverted from patient dosing based on determined activity information for the eluate.